Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

Revised FIGO Staging System

Article information

J Korean Med Assoc. 2010;53(3):245-249
Publication date (electronic) : 2010 March 31
doi : https://doi.org/10.5124/jkma.2010.53.3.245
Hee Sug Ryu, MD
Department of Obstetrics and Gynecology, Ajou University School of Medicine, Korea. hsryu@ajou.ac.kr

Abstract

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging system for carcinoma of the vulva, cervix, and endometrium in 2009. A new staging system for uterine sarcoma has been designed. This review summarizes the changes. There were minor changes in carcinoma of endometrium and cervix. The staging systems for uterine sarcomas were newly developed. Major changes were made for the carcinoma of vulva. There were no changes for cancer of the ovary, tube, vagina, and gestational trophoblastic neoplasia.

Keywords: FIGO staging; Gynecologic cancer

References

1. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009. 105103–104.
2. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009. 105109.
3. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009. 105107–108.
4. Burghardt E, Ostor A, Fox H. The new FIGO definition of cervical cancer stage IA: a critique. Gynecol Oncol 1997. 651–5.
5. Cheng X, Cai S, Li Z, Tang M, Xue M, Zang R. The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol 2004. 247.
6. Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH, Woodward PJ, Pannu HK, Amendola M, Mitchell DG. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007. 245491–498.
7. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone. Int J Radiat Oncol Biol Phys 2005. 63492–499.
8. Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 2007. 107310–315.
9. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991. 164997–1003. discussion 1003-1004.
10. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol 2009. 113895–901.
11. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet 2009. 105105–106.
12. Fons G, Hyde SE, Buist MR, Schilthuis MS, Grant P, Burger MP, van der Velden J. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 2009. 191276–1280.
13. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009. 104177–178.

Article information Continued

Copyright © 2010 Korean Medical Association

Table 1

Carcinoma of endometrium

Table 1

*Either G1, G2, G3.

**Endocervical glandular involvement only should be consid-ered as Stage I and no longer as Stage II.

#Positive cytology has to be reported separately without changing the stage.

Table 2

Carcinoma of the cervix uteri

Table 2

*All macroscopically visible lesions-even with superhicial invasion-are allotted to stage IB carcinomas. Invasion is limited to a measured stromal invasion with a maximal depth of 5.00 mm and a horizontal extension of not >7.00 mm. Depth of invasion should not be >5.00 mm taken from the base of the epithelium of the original tissue-superficial or glandular. The depth of invasion should always be reported in mm, even in those cases with "early (minimal) stromal invasion" (~1 mm).

**On rectal examination, there is no cancer-free space between the tumor and the pelvic wall. All cases with hydronephrosis or non-functioning kidney are included, unless they are known to be due another cause.

Table 3

Carcinoma of the vulva

Table 3

*The depth of invasion is definde as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion.

Table 4

Staging for uterine sarcomas (leiomyosarcomas, endometrial stromal sarcomas, adenosarcomas, and carcionsarcomas)

Table 4

*Note: Simultaneous tumors of the uterine corpus and ovary/pelvis in association with ovarian/pelvic endometriosis should be classified as independent primary tumors.